Generics 33

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Propofol manufacturers

33 products found

Filters

33 products found

propofol

Solution for injection/infusion 1 %, 2 % - 20 ml, 50 ml, 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 5 days

propofol

Vials 10 mg/ml, 20 mg/ml - 20 ml, 50 ml, 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Belarus , Iraq , Kazakhstan , Mexico , Russia , Ukraine , Uzbekistan , Vietnam
Registered in
Mexico
Available for
Licensing with supply, Distribution only
Comments
DCP submitted
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

propofol

Emulsion for injection 10 mg/ml - 20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
EU GMP, PICS, Saudi Arabia
Unavailable markets
Philippines
Available for
Licensing with supply, Distribution only
Manufacturer #559

Manufacturer usually replies in 8 days

propofol

Ampoules 10 mg/ml - 20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Comments
DCP submitted
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

propofol

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20368

Manufacturer usually replies in 5 days

propofol

Ampoules, injection 200 mg / 20 ml - 20ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Uruguay
GMP approvals
WHO
Manufacturer #18917
The company is characterized by constant development, with permanent investment in improving quality standards, technology, and training of its personnel, allowing it to be recognized among the top 5 pharmaceutical companies in the country, thus consolidating its brands both in the local market and regional.

Manufacturer usually replies in 2 days

propofol

Ampoules, injection 1%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16528
The company is based on superlative medicinal services as well as provides wellness like never before. The company provides health and allied solutions to both men and women.

Manufacturer usually replies in 3 days

propofol

Solution for injection 1%, 2% - 1ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #8104
It was established in the late 1950s. It has been making significant efforts to protect the healthy lives of human beings by producing a variety of treatments starting with injection Products. The company operates its business for various customers including business clients, patients, pharmacists, and doctors. They are trying to make their supply chain more effective to provide the necessary medicines faster.

Manufacturer usually replies in 4 days

propofol

Emulsion for injection/infusion 10 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
WHO
Manufacturer #1274

Manufacturer usually replies in 3 days

propofol

Emulsion for injection 0.2 g, 0.5 g, 1.0 g - 20 ml , 50 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Manufacturer #12677

Manufacturer usually replies in 4 days

propofol

Vials, injection 10 mg/ml - 20 ml, 50 ml, 100 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: ANDA to be filed in Q4-2023, approval expected Q4-2024; US RLD / Holder: Diprivan / Fresenius Kabi; Indication: Intravenous (IV) sedative-hypnotic agent. Used in the induction and maintenance of anesthesia or sedation ;
Manufacturer #8216

Manufacturer usually replies in 6 days

propofol

Injection 10 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30013

Manufacturer usually replies in 2 days

propofol

Injection 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

propofol

Injection 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

propofol

Ampoules, injection 200 mg/20ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18736
It was founded in the 2000s. The main aim of the position itself in the market as a company dedicated to the research, development, manufacturing, marketing, and distribution of new generation specialized generic and biosimilar medicines.

Manufacturer usually replies in 7 days

propofol

Vials, injection 10 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18331

Manufacturer usually replies in 10 days

propofol

Vials, injection 1% - 20 ml, 50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18256

Manufacturer usually replies in 6 days

propofol

Emulsion for injection 10 mg/mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #17642
This is a known company that operates in the wholesale trade of pharmaceutical products for human as well as veterinary use. The company's portfolio includes high-quality drugs that combine with the best of its return and output at the same time.

Manufacturer usually replies in 9 days

propofol

Emulsion for injection/infusion 200 mg/20 ml, 400 mg/20 m, 500 mg/50 ml, 1000 mg/50 ml - 20 ml, 50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Unavailable markets
Georgia
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

propofol

Ampoules, injection 200 mg - 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16970
They are a leading pharmaceutical company in the manufacture and marketing of drugs for hospital and outpatient use for human health care. With an extensive history of more than 80 years, the company affirms its commitment to health on a day-to-day basis, producing pharmaceutical products of excellent quality, broad production support, and available to the entire community.

Manufacturer usually replies in 7 days

Want to view all 33 products? Create your free account today!

Propofol Manufacturers

Propofol manufacturer is classified as a general anesthetic and is available in the market under the trade name Diprivan. It can be used for procedural sedation, beginning and maintaining general anaesthesia, and sedating people who are mechanically ventilated. It is commonly indicated for initiating and maintaining MAC (monitored anesthesia care) sedation, combined sedation, regional anesthesia, induction and maintenance of general anesthesia and sedation of intubated and mechanically ventilated patients in ICU. The main route for propofol administration is the intravenous (IV) route. But if a combination of drugs is used then the drug can be given in infusion form. The side effects of this pharmaceutical medicine include symptoms such as; hypotension, apnea, injection site stinging, respiratory acidosis, hypertension and hypertriglyceridemia. Propofol is not recommended for patients who have a history of hypersensitivity to the drug. Any patient with abnormally low blood pressure should be treated with caution. According to some package inserts, propofol should not be given to people who have allergies to eggs, egg products and soy products. This pharmaceutical medicine is categorized as category “B”, that means that it is safe to be administered during pregnancy but should be only taken at times of utmost need, as the drug can cross the placenta and can cause respiratory depression in the neonate. In lactating women, it does not affect the baby as a very minute amount of it is secreted in mother’s milk. FDA has granted permission to Europe that unapproved pharmaceutical medicine, Propofol-Lipuro, 1% injectable emulsion for infusion in 100 mL can be used in case of emergency, to maintain sedation via continuous infusion in patients over the age of 16, who are in ICU and those who require mechanical ventilation. If you are allergic to eggs, egg products, soybeans, or soy products, the FDA advises against using propofol. Children under the age of three and unborn children whose mother takes anaesthesia medication during late pregnancy are both at risk of having their brain development affected. When the anaesthetic is used for multiple procedures or for a duration of three hours or more, these symptoms can be more likely to occur. Later learning or behaviour issues may result from effects on brain development.

How does Propofol work?

This pharmaceutical remedy restricts syntaxin 1A, which is required at synapses of all neurons. This results in reduced communication between brain neurons, thus causing anesthesia. An injection of propofol is used to induce sleep or relaxation prior to and during surgery or other medical operations. This drug has sedative and anaesthetic properties. In the intensive care unit, coronavirus (COVID-19) patients who require mechanical ventilation can also be sedated with propofol (ICU).

The Cost of Propofol

An online search for the wholesale price for sale of Propofol for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. 100ml intravenous emulsion of propofol manufacturer(10mg/ml) costs approximately $27. The prices may differ slightly among different pharmacies.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Propofol distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Propofol suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Propofol. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Propofol is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Propofol suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Propofol Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.